These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 31582742

  • 1. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
    Xu X, Gu J, Ding X, Ge G, Zang X, Ji R, Shao M, Mao Z, Zhang Y, Zhang J, Mao F, Qian H, Xu W, Cai H, Wang F, Zhang X.
    Cell Death Dis; 2019 Oct 03; 10(10):752. PubMed ID: 31582742
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
    Zhang Q, Cheng S, Cao L, Yang J, Wang Y, Chen Y.
    Biosci Rep; 2020 Mar 27; 40(3):. PubMed ID: 32077915
    [Abstract] [Full Text] [Related]

  • 5. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
    Gao W, Chen X, Chi W, Xue M.
    Int J Mol Med; 2020 Nov 27; 46(5):1743-1754. PubMed ID: 33000222
    [Abstract] [Full Text] [Related]

  • 6. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X, Sun L, Wang L, Yao B, Mo H, Yang W.
    Biomed Pharmacother; 2019 Oct 27; 118():109386. PubMed ID: 31545291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
    Zang X, Gu J, Zhang J, Shi H, Hou S, Xu X, Chen Y, Zhang Y, Mao F, Qian H, Zhu T, Xu W, Zhang X.
    Cell Death Dis; 2020 Apr 02; 11(4):215. PubMed ID: 32242003
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
    Wei C, Wang H, Xu F, Liu Z, Jiang R.
    Biomed Pharmacother; 2018 Aug 02; 104():137-144. PubMed ID: 29772433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.
    Guo Y, Bai M, Lin L, Huang J, An Y, Liang L, Liu Y, Huang W.
    Biomed Pharmacother; 2019 Oct 02; 118():109272. PubMed ID: 31376657
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.